cdmo.directory
← Compare landing

uBriGene vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ubrigene/viralgen

CategoryuBriGeneViralgen
Listed sitebothcdmo
SummaryuBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • AAV / Viral Vector Platform
  • Gene Therapy
Indications
  • Oncology
  • Rare Disease
Locations
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.